The Asian Scientist 100
Lu Ke
Institution
Chinese Academy of Sciences
Country
China
Field
Materials Sciences
Lu is the winner of the 2020 Future Science Prize (Physical Science Prize) for discovering and synthesizing a superior nanotwinned structure and gradient nanostructure.
(Photo: Future Science Prize)
AWARDS
- Future Science Prize 2020
Related articles
Traffic Woes? Big Data To The Rescue
OpenTraffic, an open-source big data platform, provides real-time traffic data to transportation agencies and city planners in Manila in the hopes of reducing traffic congestion.
Elsevier: Lack Of Women Scientists In South Korea, India
In the first gender benchmarking study of its kind, researchers have found that the number of women in scientific fields is alarmingly low in countries such as South Korea and India.
Assaults 40 Times More Deadly For India Women Than US Counterparts
Scientists from India, US and Sweden revealed that women in India are nearly 40 times more likely to die after an assault compared to their US peers.
Compliments Help People Perform Tasks Better, Study
Japanese scientists have found evidence that people performing tasks appear to perform better when another person compliments them.
Soft Tissue X-Ray Could Help Cystic Fibrosis Patients
A new X-ray system that allows the imaging of soft tissue could be used to non-invasively track the effectiveness of treatments for cystic fibrosis.
10 Medical Devices That Changed The World
Medical devices may sound like a modern invention, but they in fact have helped us manage and treat diseases for centuries. Here are our top ten picks of medical gadgets that play a significant role in our lives, many of them so ubiquitous that we sometimes take them for granted.
WuXi Begins Construction Of New Facility In Philadelphia
WuXi PharmaTech's intended 45,000 square feet facility will be for the manufacture of cell-based therapeutics.
WuXi To Offer Foundation’s Genomic Profiling In China
WuXi has been licensed to perform the FoundationOne® assay, providing the best-in-class genomics platform to biopharmaceuticals in China.
WuXi To Build Third Cell Therapy Facility
The company's third cell therapy manufacturing facility will focus on chimeric antigen receptor T cells for cancer immunotherapy.